|The FRAP1 mtor (Catalog #MBS153276) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s TOR can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).
TOR peptide is used for blocking the activity of TOR antibody. Researchers should empirically determine the suitability of the FRAP1 mtor for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The FRAP1 mtor product has the following accession number(s) (GI #4826730) (NCBI Accession #NP_004949) (Uniprot Accession #P42345). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 15 amino acids near the amino terminus of human TOR. Blood, Bone, Brain, Heart, Kidney, Liver, Lung, Muscle, Prostate, Vascular tissues are correlated with this protein. FRAP1 also interacts with the following gene(s): AKT1, EIF4EBP1, FKBP1A, MAPKAP1, MLST8, RHEB, RICTOR, RPS6KB1, RPTOR, TSC2. The following patways have been known to be associated with this gene. Adenocarcinoma, Breast Neoplasms, Carcinoma, Renal Cell, Cardiovascular Diseases, Disease Models, Animal, Inflammation, Kidney Diseases, Liver Diseases, Lung Neoplasms, Neoplasms, Experimental are some of the diseases may be linked to TOR Peptide.